Active Ingredient(s): Mivacurium
FDA Approved: * January 22, 1992
Pharm Company: * ABBOTT
Category: Muscle Relaxer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mivacron Overview

Mivacurium chloride (formerly recognized as BW1090U81, BW B1090U or BW1090U) is a short-duration non-depolarizing neuromuscular-blocking drug[1] or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs,[2] used adjunctively in anesthesia to facilitate endotracheal intubation[3] and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Contents 1 Structure 2 Pharmacology 3 Availabili...

Read more Mivacron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mivacurium_chloride

Recent Mivacron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 0.5mg/ml, 2mg/ml, 50mg/100ml
  • Solution: 10mg/5ml (2mg/ml), 20mg/10ml (2mg/ml), 2mg/ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mivacron: (2 results)

Sorted by National Drug Code
  • 0074-4365 Mivacron 2 mg/ml Intravenous Solution by Abbvie Inc.
  • 63379-066 Mivacron 2 mg/ml Intravenous Solution by Glaxo Operations Uk Ltd

Other drugs which contain Mivacurium or a similar ingredient: (1 result)

Related Mivacron Topics: